4.6 Review

Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human

Journal

FEBS JOURNAL
Volume 277, Issue 8, Pages 1805-1821

Publisher

WILEY
DOI: 10.1111/j.1742-4658.2010.07607.x

Keywords

ASH1; ASH2; COMPASS; histone H3 lysine 4; histone methyltransferase; MLL; Set1; TAC1; TRX; WDR5

Funding

  1. National Institutes of Health [1R15GM088798-01]
  2. American Heart Association [0635008N]
  3. American Cancer Society [06-52]
  4. Mallinckrodt Foundation
  5. Southern Illinois University

Ask authors/readers for more resources

The fourth lysine of histone H3 is post-translationally modified by a methyl group via the action of histone methyltransferase, and such a covalent modification is associated with transcriptionally active and/or repressed chromatin states. Thus, histone H3 lysine 4 methylation has a crucial role in maintaining normal cellular functions. In fact, misregulation of this covalent modification has been implicated in various types of cancer and other diseases. Therefore, a large number of studies over recent years have been directed towards histone H3 lysine 4 methylation and the enzymes involved in this covalent modification in eukaryotes ranging from yeast to human. These studies revealed a set of histone H3 lysine 4 methyltransferases with important cellular functions in different eukaryotes, as discussed here.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available